US 11981897
Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression
granted A61PA61P21/00A61P21/02
Quick answer
US patent 11981897 (Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression) held by Ionis Pharmaceuticals, Inc. expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P21/00, A61P21/02